This is particularly interesting as PD-L1 has been identified to play a pivotal role in licensing glycolytic metabolism of tumor cells via AKT/mTOR, which limits nutrients needed for T cell survival and function [47]. The gene discussed is MTOR; the disease is neoplasm.